Regeneron Pharmaceuticals said on Tuesday it had entered into a deal valued at more than $3 billion with contract drug ...

The U.S. Food and Drug Administration (FDA) has approved Ferring Pharmaceuticals’ drug product manufacturing hub in ...

PCI Pharma Services is acquiring an entire equity stake in Ajinomoto Althea Inc. (Althea), a U.S.-based sterile fill-finish ...

How CDMOs are reshaping pharmaceutical partnerships through friendshoring, risk-sharing economics, and specialized development capabilities.

PCI Pharma Services, (“PCI”)a leading global contract development and manufacturing ...

Aspen Pharmacare’s shares plunged as much as 33% (losing over R53 a share) on Wednesday afternoon, but later recovered ...

(Reuters) -Regeneron Pharmaceuticals said on Tuesday it has signed a deal worth more than $3 billion with contract drug ...

At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...

Major drug companies are beginning to deliver their first-quarter readouts to Wall Street analysts, revealing their ...

April 22 (Reuters) - Regeneron Pharmaceuticals ... worth more than $3 billion with contract drug developer Fujifilm Diosynth, potentially doubling its U.S. manufacturing capacity and bringing ...

Amman, Jordan: Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on ...